Comparative Frequency of Venous Thromboembolism in Patients Admitted to the Hospital with SARS-CoV-2 Infection versus Community-acquired Pneumonia.
作者信息
Hendrickson Kathryn W, Knox Daniel B, Bledsoe Joseph R, Peltan Ithan D, Jacobs Jason R, Lloyd James F, Dean Nathan C, Woller Scott C, Brown Samuel M
机构信息
Intermountain Medical Center Salt Lake City, Utah.
University of Utah Salt Lake City, Utah.
出版信息
Ann Am Thorac Soc. 2022 Jul;19(7):1233-1235. doi: 10.1513/AnnalsATS.202108-953RL.
Abstract
摘要
相似文献
1
Comparative Frequency of Venous Thromboembolism in Patients Admitted to the Hospital with SARS-CoV-2 Infection versus Community-acquired Pneumonia.感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的住院患者与社区获得性肺炎患者静脉血栓栓塞的比较发生率
Ann Am Thorac Soc. 2022 Jul;19(7):1233-1235. doi: 10.1513/AnnalsATS.202108-953RL.
2
The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.严重急性呼吸综合征冠状病毒 2 感染的危重病患者与严重流感和社区获得性肺炎患者的静脉血栓栓塞发生率：一项回顾性图表回顾。
Med Sci (Basel). 2022 Jun 8;10(2):30. doi: 10.3390/medsci10020030.
3
Letter by Hamilton et al Regarding Article, "Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients".汉密尔顿等人就文章《COVID-19肺炎与社区获得性肺炎患者静脉血栓栓塞风险的比较》所写的信。
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):e309-e310. doi: 10.1161/ATVBAHA.120.315235. Epub 2020 Oct 21.
4
Is procalcitonin a reliable marker of bacterial community-acquired pneumonia in adults admitted to the emergency department during SARS-CoV-2 pandemic?在2019冠状病毒病大流行期间，降钙素原是否是急诊科收治的成年患者社区获得性细菌性肺炎的可靠标志物？
Eur J Emerg Med. 2021 Aug 1;28(4):312-314. doi: 10.1097/MEJ.0000000000000796.
5
COVID-19 pandemic and the incidence of community-acquired pneumonia in elderly people.COVID-19 大流行和老年人社区获得性肺炎的发病率。
Respir Investig. 2020 Nov;58(6):435-436. doi: 10.1016/j.resinv.2020.09.001. Epub 2020 Sep 18.
6
No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020.在 2020 年 3 月 COVID-19 高峰之前，德国 CAPNETZ 社区获得性肺炎队列中未检测到 SARS-CoV-2。
Infection. 2020 Dec;48(6):971-974. doi: 10.1007/s15010-020-01471-y. Epub 2020 Jul 3.
7
COVID-19 and its implication for venous thromboembolism.新型冠状病毒肺炎及其对静脉血栓栓塞症的影响。
Cardiol J. 2020;27(5):481-484. doi: 10.5603/CJ.2020.0153.
8
Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia.肺炎严重指数和 CURB-65 评分是预测 SARS-CoV-2 社区获得性肺炎住院患者死亡率的良好指标。
Chest. 2022 Apr;161(4):927-936. doi: 10.1016/j.chest.2021.10.031. Epub 2021 Nov 2.
9
Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis.新冠病毒感染患者出院后静脉血栓栓塞事件的发生率：一项系统评价和荟萃分析。
Thromb Res. 2022 Jan;209:94-98. doi: 10.1016/j.thromres.2021.11.029. Epub 2021 Dec 7.
10
Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic.COVID-19 大流行期间社区获得性肺炎的治疗。
Ann Intern Med. 2020 Aug 18;173(4):304-305. doi: 10.7326/M20-2189. Epub 2020 May 7.
引用本文的文献
1
T Cell Receptor Sequences Amplified during Severe COVID-19 and Multisystem Inflammatory Syndrome in Children Mimic SARS-CoV-2, Its Bacterial Co-Infections and Host Autoantigens.严重 COVID-19 和儿童多系统炎症综合征期间扩增的 T 细胞受体序列模拟 SARS-CoV-2、其细菌共感染和宿主自身抗原。
Int J Mol Sci. 2023 Jan 10;24(2):1335. doi: 10.3390/ijms24021335.
2
Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies.SARS-CoV-2、腺病毒和细菌抗原诱导的互补自身抗体与 COVID-19 凝血障碍中的人血蛋白抗原发生交叉反应。
Int J Mol Sci. 2022 Sep 29;23(19):11500. doi: 10.3390/ijms231911500.
本文引用的文献
1
Natural Language Processing Performance for the Identification of Venous Thromboembolism in an Integrated Healthcare System.自然语言处理在集成医疗保健系统中识别静脉血栓栓塞症的性能。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211013108. doi: 10.1177/10760296211013108.
2
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.COVID-19 住院患者静脉血栓栓塞症和出血的发生率：系统评价和荟萃分析。
Chest. 2021 Mar;159(3):1182-1196. doi: 10.1016/j.chest.2020.11.005. Epub 2020 Nov 17.
3
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.科学与标准化委员会通讯：新型冠状病毒肺炎住院患者静脉血栓栓塞症诊断、预防及治疗的临床指南
J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929.
4
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞：一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
5
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.意大利米兰一家学术医院收治的 COVID-19 患者的静脉和动脉血栓栓塞并发症。
Thromb Res. 2020 Jul;191:9-14. doi: 10.1016/j.thromres.2020.04.024. Epub 2020 Apr 23.
6
Implementation of Real-Time Electronic Clinical Decision Support for Emergency Department Patients with Pneumonia Across a Healthcare System.在整个医疗系统中为急诊科肺炎患者实施实时电子临床决策支持
AMIA Annu Symp Proc. 2020 Mar 4;2019:353-362. eCollection 2019.
7
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
8
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
9
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.住院内科患者静脉血栓栓塞症和出血的预后因素：系统评价和荟萃分析。
Blood. 2020 May 14;135(20):1788-1810. doi: 10.1182/blood.2019003603.
10
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
Zotero 插件